Last reviewed · How we verify
WST 11 -mediated -VTP — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
WST 11 -mediated -VTP (WST 11 -mediated -VTP) — Steba Biotech S.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| WST 11 -mediated -VTP TARGET | WST 11 -mediated -VTP | Steba Biotech S.A. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- WST 11 -mediated -VTP CI watch — RSS
- WST 11 -mediated -VTP CI watch — Atom
- WST 11 -mediated -VTP CI watch — JSON
- WST 11 -mediated -VTP alone — RSS
Cite this brief
Drug Landscape (2026). WST 11 -mediated -VTP — Competitive Intelligence Brief. https://druglandscape.com/ci/wst-11-mediated-vtp. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing